Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations
- PMID: 16972717
- DOI: 10.1002/bimj.200610248
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations
Abstract
This is a discussion of the following two papers in this special issue on adaptive designs: 'Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: General concepts' by Frank Bretz, Heinz Schmidli, Franz König, Amy Racine and Willi Maurer, and 'Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: Applications and practical considerations' by Heinz Schmidli, Frank Bretz, Amy Racine and Willi Maurer.
Comment on
-
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.Biom J. 2006 Aug;48(4):623-34. doi: 10.1002/bimj.200510232. Biom J. 2006. PMID: 16972714
-
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations.Biom J. 2006 Aug;48(4):635-43. doi: 10.1002/bimj.200510231. Biom J. 2006. PMID: 16972715
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources